TScan Therapeutics
TCRX · NASDAQ
$0.224+$0.0138 (+6.57%)TodayMarket closed ·
Prev close $0.2102
Who owns TCRX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 44.6% of TCRX’s shares.
- Lynx1 Capital Advisors LLC12.3%
- BVF Partners L.P.8.5%
- K2 HealthVentures LLC5.5%
- Baker Bros. Advisors LP4.3%
- Next 6 largest institutions14.0%
- All other shareholders55.4%
| Holder | Shares | % of shares |
|---|---|---|
| Lynx1 Capital Advisors LLC | 8.02M | 12.27% |
| BVF Partners L.P. | 5.56M | 8.51% |
| K2 HealthVentures LLC | 3.60M | 5.51% |
| Baker Bros. Advisors LP | 2.78M | 4.26% |
| Vanguard Capital Management, LLC | 2.16M | 3.30% |
| Two Sigma Investments, LP | 1.95M | 2.98% |
| Renaissance Technologies LLC | 1.33M | 2.03% |
| Acadian Asset Management LLC | 1.31M | 2.00% |
| Bessemer Venture Partners | 1.25M | 1.91% |
| Millennium Management LLC | 1.16M | 1.78% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.84M | 2.82% |
| abrdn Life Sciences Investors | 836.78K | 1.28% |
| Vanguard Extended Market Index Fund | 665.75K | 1.02% |
| BlackRock Health Sciences Opportunities Portfolio | 556.65K | 0.85% |
| BlackRock Health Sciences Trust II | 407.01K | 0.62% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of TCRX in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| ZDRAVESKI ZORAN | Award | 300.00K | — |
| MacBeath Gavin | Award | 1.00M | — |
| Woods Keith | Award | 67.00K | — |
| Gruia Gabriela | Award | 67.00K | — |
| Klencke Barbara | Award | 67.00K | — |
| Nicholson Garry A | Award | 67.00K | — |
| Dorton Katina | Award | 67.00K | — |
| BAKER JULIAN | Award | 67.00K | — |
| BAKER JULIAN | Award | 67.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.49M
- Days to cover
- 3.25
- % of shares outstanding
- 3.80%
- Average daily volume
- 764.43K
- Change since last report
- +9.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.